Drug profile · INN
ixekizumab
TALTZ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ixekizumab (TALTZ) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN ixekizumab
Brand TALTZ
Route INJECTION
Formulation INJECTABLE
ATC code L04AC13
Frequently asked questions
What is ixekizumab?
ixekizumab (TALTZ) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ixekizumab?
TALTZ is a marketed brand name for ixekizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ixekizumab?
ixekizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.